6.020

- (-%)
Range 5.861 - 6.172   (5.31%)
Open 6.060
Previous Close 6.020
Buy Price 6.020
Buy Volume 10
Sell Price 6.160
Sell Volume 8
Volume 2,395
Value -
Remark
Measurement Type Value
EPS (USD) -0.942
Trailing EPS (USD) -0.762
NAV (USD) 10.898
Cash In Hand (USD) 10.897
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV 0.725
Price / Cash In Hand 0.725
Issued & Paid-up Shares 6,891,970
Treasury Shares -
Market Cap (M) 54.447
Par Value (USD) n.a.
Beta - 75 Days 1.578
R-Squared - 75 Days(%) 1.83
Beta - 500 Days 0.908
R-Squared - 500 Days(%) 0.25
ISIN Code -
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 21 Sep 2021 22:19.
Data powered by
View All Events

About FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS

Forward Pharma A/S is a biopharmaceutical company. The Company is focusing to initiate a Phase III clinical trial using FP187, a formulation of dimethyl fumarate (DMF), for the treatment of multiple sclerosis (MS), patients. FP187, the Company�s clinical candidate, is a DMF formulation in a delayed and slow release oral dose, which it plans to advance for the treatment of relapsing remitting MS, or RRMS, and other immune disorders, such as psoriasis.

Loading Chart...